We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why I’d buy these 2 UK dividend shares in an ISA today to make a passive income

These two UK dividend shares could offer a growing passive income, in my view. Buying them in an ISA today could be a shrewd move.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Making a passive income from UK shares has become more challenging in 2020. Many FTSE 100 and FTSE 250 companies have reduced or postponed their dividends due to difficult trading conditions.

However, it’s still possible to build a portfolio of income stocks at the present time. It could offer a growing income over the long run as the world economy recovers.

XXX

With that in mind, here are two UK dividend shares that could be worth buying in an ISA today. They may produce impressive total returns in the coming years.

A growing passive income

AstraZeneca (LSE: AZN) hasn’t been a particularly attractive stock through which to generate a passive income in recent years. Its dividends have failed to rise on a per share basis as a result of falling sales due to the ending of patents on key drugs.

However, the company’s recent performance shows that it could now deliver a rising dividend in the long run. For example, its first-half results showed a 14% rise in sales. There was also an increase in core earnings of 26%. That came as investment in its product pipeline has begun to positively impact on its financial performance.

Looking ahead, AstraZeneca is expected to deliver a 27% rise in net profit next year. It trades on a price-to-earnings growth (PEG) ratio of around 0.9. That suggests it offers capital growth potential as well as the prospect of a rising passive income in the coming years.

Improving operating conditions

Polymetal (LSE: POLY) is another FTSE 100 dividend stock that could offer a sound means of generating a growing passive income. The gold miner has enjoyed strong operating conditions this year, with the precious metal’s price increasing by around 25% in 2020.

This contributed to a 98% rise in the company’s underlying profitability in the first half of the year. Its bottom line benefitted from a 21% increase in sales, while it was able to reduce total cash costs by 4%. It also increased capital expenditure by 31%, with its development programme currently on track.

Polymetal currently has a dividend yield of 6.3%. It’s forecast to raise dividends per share next year so that it has a forward yield of almost 9%. While this is clearly dependent on the gold price, the company’s yield suggests it has a wide margin of safety. And that could prove to be a worthwhile passive income investing opportunity.

Buying income shares in an ISA

Of course, buying stocks such as AstraZeneca and Polymetal in an ISA could be a sound means of making a passive income. ISAs offer significant flexibility in terms of penalty-free withdrawals alongside their tax advantages.

While the economic outlook remains uncertain, building a portfolio of UK dividend shares could be a means of obtaining a worthwhile income in the coming years.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »